日科化学(300214) - 2023 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2023 was ¥583,133,877.71, a decrease of 20.72% compared to ¥735,574,870.44 in the same period last year[5] - The net profit attributable to shareholders for Q1 2023 was ¥17,727,842.35, down 78.10% from ¥80,938,188.27 in the previous year[5] - The company reported a significant decrease in total profit, which was ¥21,499,163.10, down 78.85% from ¥101,674,709.53 in the same period last year[12] - The company’s diluted earnings per share for Q1 2023 was ¥0.04, a decrease of 76.47% compared to ¥0.17 in the previous year[5] - Total operating revenue for Q1 2023 was CNY 583.13 million, a decrease of 20.7% compared to CNY 735.57 million in Q1 2022[22] - Net profit for Q1 2023 was CNY 17.69 million, a decline of 78.1% from CNY 80.94 million in Q1 2022[23] - Earnings per share for Q1 2023 were CNY 0.04, compared to CNY 0.17 in Q1 2022[24] Cash Flow - The net cash flow from operating activities increased significantly by 366.33%, reaching ¥46,909,900.09 compared to ¥10,059,329.13 in Q1 2022[5] - The net cash flow from financing activities surged by 932.94% to ¥54,326,467.00, attributed to increased bank borrowings for project support[13] - The net cash flow from financing activities for the current period is ¥54,326,467.00, up from ¥5,259,412.82 in the previous period, representing an increase of about 935.5%[27] - Total cash inflow from operating activities decreased to ¥560,953,053.94 from ¥636,845,678.15, reflecting a decline of about 11.9%[25] - Cash outflow from operating activities also decreased to ¥514,043,153.85 from ¥626,786,349.02, indicating a reduction of approximately 17.9%[25] - The net cash flow from investment activities is negative at -¥113,453,896.17, compared to a positive ¥60,468,260.70 in the previous period[27] - Cash inflow from financing activities increased to ¥89,470,729.70 from ¥6,034,128.40, marking an increase of approximately 1,480.5%[27] - The ending balance of cash and cash equivalents decreased to ¥102,080,989.23 from ¥152,840,054.13, a decline of approximately 33.1%[27] Assets and Liabilities - The total assets at the end of Q1 2023 were ¥3,064,685,388.36, a slight increase of 0.58% from ¥3,046,987,882.64 at the end of the previous year[5] - The company's total liabilities amounted to CNY 519.06 million, slightly down from CNY 521.06 million in the previous quarter[23] - Total equity attributable to shareholders was CNY 2.55 billion, an increase from CNY 2.53 billion in the previous quarter[23] - Current assets decreased from 1,553,737,085.71 RMB to 1,215,790,275.39 RMB[19] - The total assets of the company reached CNY 3.06 billion, slightly up from CNY 3.05 billion in the previous quarter[23] Shareholder Information - The total number of common shareholders at the end of the reporting period is 14,778[14] - The largest shareholder, Zhao Dongri, holds 17.52% of shares, totaling 81,785,037 shares[14] Investments and Projects - The company plans to invest 950 million RMB in a project to produce 60,000 tons of lithium battery electrolyte raw materials annually[15] - A joint venture was established to invest in a project with an annual capacity of 600,000 tons of film and products, with a total investment of 152 million RMB[16] - The company has invested 6 million RMB to establish a joint venture for steam supply, with a registered capital of 20 million RMB[17] Research and Development - Research and development expenses rose by 117.75% to ¥11,338,619.86, reflecting the company's commitment to enhancing product offerings and adapting to market changes[12] - Research and development expenses increased to CNY 11.34 million, up 117.5% from CNY 5.21 million in the previous year[23]